ZECLAR Side Effects

6260656-8 | Convulsion, Hypocalcaemia, Hyponatraemia, Hypophosphataemia, Postictal State
on Jun 29, 2009 Male patient from FRANCE , 70 years of age, was diagnosed with productive cough, hiccups, arrhythmia (What is arrhythmia?), asthma (What is asthma?) and was treated with Zeclar (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, hypocalcaemia, hyponatraemia, hypophosphataemia, postictal state. Zeclar dosage: . During the same period patient was treated with SURGAM (View Surgam Review and Surgam Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CARBOCYSYTEIN (View Carbocysytein Review and Carbocysytein Label ), SPASFON (View Spasfon Review and Spasfon Label ), ROCGEL (View Rocgel Review and Rocgel Label ), RYTHMOL (View Rythmol Review and Rythmol Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), AERIUS (View Aerius Review and Aerius Label ). Patient was hospitalized.

6159307-2 | Arrhythmia, Cytolytic Hepatitis, Diarrhoea, Disseminated Intravascular Coagulation, Hypovolaemic Shock, Lactic Acidosis, Leukopenia, Multi-organ Failure
Patient was taking Zeclar (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), cytolytic hepatitis, diarrhoea, disseminated intravascular coagulation, hypovolaemic shock, lactic acidosis, leukopenia, multi-organ failure on Apr 16, 2009 from FRANCE Additional patient health information: Female patient , 71 years of age, was diagnosed with helicobacter infection, gout (What is gout?) and. Zeclar dosage: . During the same period patient was treated with COLCHIMAX (View Colchimax Review and Colchimax Label ), IXPRIM (View Ixprim Review and Ixprim Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6113079-6 | Palatal Oedema, Urticaria
Adverse event was reported on Mar 05, 2009 by a Male patient taking Zeclar (View Usage) (Dosage: ) was diagnosed with tonsillitis and. Location: FRANCE , 31 years of age, After Zeclar was administered, patient had the following side effects: palatal oedema, urticaria. During the same period patient was treated with ERYTHROMYCIN BASE (View Erythromycin Base Review and Erythromycin Base Label ). Patient was hospitalized.

5729189-9 | Acute Hepatic Failure, Cardiac Arrest, Cholestasis, Cytolytic Hepatitis, Hepatitis Fulminant, Hypotension, Ischaemic Hepatitis, Lung Disorder, Oral Intake Reduced
on May 02, 2008 Female patient from FRANCE , 55 years of age, was diagnosed with lung infection and was treated with Zeclar (View Usage). Patient experienced the following unwanted or unexpected effects: acute hepatic failure, cardiac arrest (What is cardiac arrest?), cholestasis, cytolytic hepatitis, hepatitis fulminant, hypotension, ischaemic hepatitis, lung disorder, oral intake reduced. Zeclar dosage: . During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ), AMOXI CLAVULANICO (View Amoxi-clavulanico Review and Amoxi-clavulanico Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.


5705588-6 | Asthenia, Bronchitis, Hypocapnia, Hypoxia, Mucosal Discolouration, Productive Cough, Pulmonary Embolism
on Apr 07, 2008 Female patient from FRANCE , 49 years of age, was diagnosed with bronchitis (What is bronchitis?), eczema (What is eczema?) and was treated with Zeclar (View Usage). Patient had the following side effects: asthenia, bronchitis (What is bronchitis?), hypocapnia, hypoxia, mucosal discolouration, productive cough, pulmonary embolism (What is pulmonary embolism?). Zeclar dosage: . During the same period patient was treated with THALIDOMIDE (View Thalidomide Review and Thalidomide Label ). Patient was hospitalized.

5695149-X | Diarrhoea, Hepatitis Cholestatic, Neutropenia, Protein C Deficiency, Protein S Deficiency, Renal Failure
Patient was taking Zeclar (View Usage). After Zeclar was administered, patient had the following side effects: diarrhoea, hepatitis cholestatic, neutropenia, protein c deficiency, protein s deficiency, renal failure on Mar 27, 2008 from FRANCE Additional patient health information: Male patient , weighting 140.0 lb, was diagnosed with helicobacter infection, gout (What is gout?), pain (What is pain?) and. Zeclar dosage: . During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), LENALIDOMIDE (View Lenalidomide Review and Lenalidomide Label ), COLCHICINE (View Colchicine Review and Colchicine Label ), FENTANYL (Patch) (View Fentanyl Review and Fentanyl Label ), PREGABALINE (View Pregabaline Review and Pregabaline Label ), AMOXICILLINE CLAVULANIC ACID (1g/125mg) (View Amoxicilline-clavulanic Acid Review and Amoxicilline-clavulanic Acid Label ). Patient was hospitalized.

5571950-8 | Ataxia, Overdose, Vomiting
Adverse event was reported on Dec 14, 2007 by a Female patient taking Zeclar (View Usage) (Dosage: ) was diagnosed with acute sinusitis, partial seizures and. Location: FRANCE , child 3 years of age, Patient experienced the following unwanted or unexpected effects: ataxia (What is ataxia?), overdose, vomiting. During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ). Patient was hospitalized.

5460674-3 | Rash Erythematous, Rash Maculo-papular, Rash Pruritic, Renal Failure Acute
on Sep 11, 2007 Female patient from FRANCE , 89 years of age, weighting 72.75 lb, was diagnosed with helicobacter infection and was treated with Zeclar (View Usage). Patient had the following side effects: rash erythematous, rash maculo-papular, rash pruritic, renal failure acute. Zeclar dosage: . During the same period patient was treated with AMOXICILLIN + CLAVULANATE POTASSIUM (View Amoxicillin + Clavulanate Potassium Review and Amoxicillin + Clavulanate Potassium Label ), ANTICOAGULANT (View Anticoagulant Review and Anticoagulant Label ). Patient was hospitalized.

5446847-4 | Infectious Mononucleosis
on Sep 03, 2007 Female patient from FRANCE , weighting 158.7 lb, was diagnosed with tonsillitis, contraception and was treated with Zeclar (View Usage). After Zeclar was administered, patient had the following side effects: infectious mononucleosis (What is infectious mononucleosis?). Zeclar dosage: . During the same period patient was treated with CYPROTERONE ETHINYLESTRADIOL (View Cyproterone Ethinylestradiol Review and Cyproterone Ethinylestradiol Label ).

5443731-7 | Hiccups
Patient was taking Zeclar (View Usage). Patient experienced the following unwanted or unexpected effects: hiccups on Aug 27, 2007 from FRANCE Additional patient health information: Male patient , 38 years of age, weighting 110.2 lb, was diagnosed with bronchitis (What is bronchitis?), cough and. Zeclar dosage: . During the same period patient was treated with GALENIC /FLUTICASONE/SALMETEROL/ (View Galenic /fluticasone/salmeterol/ Review and Galenic /fluticasone/salmeterol/ Label ).

5397868-1 | Epistaxis, International Normalised Ratio Decreased
Adverse event was reported on Jul 16, 2007 by a Female patient taking Zeclar (View Usage) (Dosage: ) was diagnosed with gastritis, hypertension and. Location: FRANCE , weighting 149.9 lb, Patient had the following side effects: epistaxis, international normalised ratio decreased. During the same period patient was treated with FLUINDIONE (View Fluindione Review and Fluindione Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ).

5392653-9 | Uveitis
on Jul 12, 2007 Female patient from FRANCE , 44 years of age, was treated with Zeclar (View Usage). After Zeclar was administered, patient had the following side effects: uveitis. Zeclar dosage: . During the same period patient was treated with ENFUVIRTIDE (View Enfuvirtide Review and Enfuvirtide Label ), EMTRICITABINE, TENOFOVIR,DISOPRAXIL (View Emtricitabine, Tenofovir,disopraxil Review and Emtricitabine, Tenofovir,disopraxil Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ). Patient was hospitalized.

5386087-0 | Haemorrhage, Prothrombin Level Decreased
on Jul 04, 2007 Female patient from FRANCE , 63 years of age, was diagnosed with helicobacter infection and was treated with Zeclar (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage, prothrombin level decreased. Zeclar dosage: . During the same period patient was treated with ANTIVITAMIN K ANTICOAGULANT (View Antivitamin K Anticoagulant Review and Antivitamin K Anticoagulant Label ).

5372542-6 | Cutaneous Vasculitis
Patient was taking Zeclar (View Usage). Patient had the following side effects: cutaneous vasculitis on Jun 20, 2007 from FRANCE Additional patient health information: Female patient , 64 years of age, was diagnosed with tonsillitis and. Zeclar dosage: . During the same period patient was treated with OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), TELITHROMYCINE (View Telithromycine Review and Telithromycine Label ). Patient was hospitalized.

5369788-X | Rash Erythematous, Rash Maculo-papular, Rash Pruritic, Renal Failure Acute
Adverse event was reported on Jun 15, 2007 by a Female patient taking Zeclar (View Usage) (Dosage: ) was diagnosed with helicobacter infection and. Location: FRANCE , 89 years of age, weighting 72.75 lb, After Zeclar was administered, patient had the following side effects: rash erythematous, rash maculo-papular, rash pruritic, renal failure acute. During the same period patient was treated with AMOXICILLIN + CLAVULANATE POTASSIUM (View Amoxicillin + Clavulanate Potassium Review and Amoxicillin + Clavulanate Potassium Label ), ANTICOAGULANT (View Anticoagulant Review and Anticoagulant Label ). Patient was hospitalized.

5367987-4 | Agranulocytosis, Anaphylactic Shock, Aplasia, Asthenia, Haemoptysis, Pneumonia, Pyrexia
on Jun 15, 2007 Female patient from FRANCE , 66 years of age, weighting 121.3 lb, was diagnosed with pyrexia, cough, glaucoma (What is glaucoma?) and was treated with Zeclar (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, anaphylactic shock, aplasia, asthenia, haemoptysis, pneumonia (What is pneumonia?), pyrexia. Zeclar dosage: . During the same period patient was treated with CLOBUTINOL (View Clobutinol Review and Clobutinol Label ), AMOXICILLIN + CLAVULANATE POTASSIUM (View Amoxicillin + Clavulanate Potassium Review and Amoxicillin + Clavulanate Potassium Label ), BRINZOLAMIDE (View Brinzolamide Review and Brinzolamide Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), DIURETICS (View Diuretics Review and Diuretics Label ). Patient was hospitalized.

5361321-1 | Agranulocytosis, Aplasia, Asthenia, Haemoptysis, Pneumonia, Pyrexia
on Jun 08, 2007 Female patient from FRANCE , 66 years of age, weighting 121.3 lb, was diagnosed with pyrexia, cough, glaucoma (What is glaucoma?) and was treated with Zeclar (View Usage). Patient had the following side effects: agranulocytosis, aplasia, asthenia, haemoptysis, pneumonia (What is pneumonia?), pyrexia. Zeclar dosage: . During the same period patient was treated with CLOBUTINOL (View Clobutinol Review and Clobutinol Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), AMOXICILLAN ACIDE CLAVULANIQUE (View Amoxicillan-acide Clavulanique Review and Amoxicillan-acide Clavulanique Label ), BRINZOLAMIDE (View Brinzolamide Review and Brinzolamide Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), DIURETICS (View Diuretics Review and Diuretics Label ), ACE INHIBITOR NOS (View Ace Inhibitor Nos Review and Ace Inhibitor Nos Label ). Patient was hospitalized.

5358886-2 | Cutaneous Vasculitis
Patient was taking Zeclar (View Usage). After Zeclar was administered, patient had the following side effects: cutaneous vasculitis on Jun 11, 2007 from FRANCE Additional patient health information: Female patient , 64 years of age, was diagnosed with tonsillitis and. Zeclar dosage: . During the same period patient was treated with OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), TELITHROMYCINE (View Telithromycine Review and Telithromycine Label ). Patient was hospitalized.

5329383-5 | Cutaneous Vasculitis
Adverse event was reported on May 10, 2007 by a Female patient taking Zeclar (View Usage) (Dosage: ) was diagnosed with tonsillitis and. Location: FRANCE , 64 years of age, Patient experienced the following unwanted or unexpected effects: cutaneous vasculitis. During the same period patient was treated with OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), TELITHROMYCINE (View Telithromycine Review and Telithromycine Label ). Patient was hospitalized.

5329298-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased
on May 10, 2007 Male patient from FRANCE , 70 years of age, was diagnosed with helicobacter gastritis, ascites, varices oesophageal and was treated with Zeclar (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased. Zeclar dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), REPAGLINIDE (View Repaglinide Review and Repaglinide Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

5308772-9 | Bacterial Infection, Bone Marrow Failure, Cardiovascular Insufficiency, Diarrhoea, Dysphagia, Lung Disorder, Nausea
on Apr 16, 2007 Male patient from FRANCE , 72 years of age, was diagnosed with bronchitis (What is bronchitis?), gout (What is gout?), hypertension and was treated with Zeclar (View Usage). After Zeclar was administered, patient had the following side effects: bacterial infection (What is bacterial infection?), bone marrow failure, cardiovascular insufficiency, diarrhoea, dysphagia, lung disorder, nausea (What is nausea?). Zeclar dosage: . During the same period patient was treated with TIEMONIUM/OPIUM/COLCHICINE (TIEMONIUM/OPIUM/COLCHICINE) (View Tiemonium/opium/colchicine (tiemonium/opium/colchicine) Review and Tiemonium/opium/colchicine (tiemonium/opium/colchicine) Label ), PRINZIDE (View Prinzide Review and Prinzide Label ). Patient was hospitalized.

5291282-5 | Respiratory Tract Congestion, Rhinorrhoea
Patient was taking Zeclar (View Usage). Patient experienced the following unwanted or unexpected effects: respiratory tract congestion, rhinorrhoea on Mar 30, 2007 from FRANCE Additional patient health information: Female patient , 33 years of age, weighting 114.6 lb, was diagnosed with cough and. Zeclar dosage: . During the same period patient was treated with HELICIDINE (View Helicidine Review and Helicidine Label ), PREDNISOLONE SODIUM SULFOBENZOATE (View Prednisolone Sodium Sulfobenzoate Review and Prednisolone Sodium Sulfobenzoate Label ). Patient was hospitalized.

5281204-5 | Bone Marrow Failure, Cardiovascular Insufficiency, Diarrhoea, Nausea, Renal Failure, Respiratory Arrest, Rhabdomyolysis
Adverse event was reported on Mar 22, 2007 by a Male patient taking Zeclar (View Usage) (Dosage: ) was diagnosed with bronchitis (What is bronchitis?), gout (What is gout?), hypertension and. Location: FRANCE , 72 years of age, Patient had the following side effects: bone marrow failure, cardiovascular insufficiency, diarrhoea, nausea (What is nausea?), renal failure, respiratory arrest, rhabdomyolysis. During the same period patient was treated with TIEMONIUM/OPIUM/COLCHICINE (TIEMONIUM/OPIUM/COLCHICINE) (View Tiemonium/opium/colchicine (tiemonium/opium/colchicine) Review and Tiemonium/opium/colchicine (tiemonium/opium/colchicine) Label ), PRINZIDE (View Prinzide Review and Prinzide Label ). Patient was hospitalized.

5269241-8 | Optic Neuritis
on Mar 12, 2007 Male patient from FRANCE , 58 years of age, was diagnosed with pulmonary tuberculosis and was treated with Zeclar (View Usage). After Zeclar was administered, patient had the following side effects: optic neuritis. Zeclar dosage: . During the same period patient was treated with ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), RIFABUTINE (View Rifabutine Review and Rifabutine Label ), MOXIFLOXACIN HCL (View Moxifloxacin Hcl Review and Moxifloxacin Hcl Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), RUFINAMIDE (View Rufinamide Review and Rufinamide Label ). Patient was hospitalized.

5261134-5 | Blood Creatine Increased, Diarrhoea, Leukocyturia, Nausea, Overdose, Proteinuria, Renal Failure, Renal Failure Acute
on Mar 02, 2007 Male patient from , 37 years of age, weighting 110.2 lb, was diagnosed with atypical mycobacterial infection, cystitis noninfective, antibiotic prophylaxis, unevaluable event and was treated with Zeclar (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine increased, diarrhoea, leukocyturia, nausea (What is nausea?), overdose, proteinuria, renal failure, renal failure acute. Zeclar dosage: . During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), RIFABUTIN (View Rifabutin Review and Rifabutin Label ). Patient was hospitalized.

5254641-2 | Blood Creatine Increased, Diarrhoea, Leukocyturia, Nausea, Overdose, Proteinuria, Renal Failure, Renal Failure Acute
Patient was taking Zeclar (View Usage). Patient had the following side effects: blood creatine increased, diarrhoea, leukocyturia, nausea (What is nausea?), overdose, proteinuria, renal failure, renal failure acute on Feb 21, 2007 from Additional patient health information: Male patient , 37 years of age, weighting 110.2 lb, was diagnosed with atypical mycobacterial infection, cystitis noninfective, antibiotic prophylaxis, unevaluable event and. Zeclar dosage: . During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), RIFABUTIN (View Rifabutin Review and Rifabutin Label ). Patient was hospitalized.

5245857-X | Condition Aggravated, Ear Pain, Headache, Infection, Oedema, Otorrhoea, Pyrexia, Retinal Disorder, Tympanic Membrane Disorder
Adverse event was reported on Feb 14, 2007 by a Male patient taking Zeclar (View Usage) (Dosage: ) was diagnosed with tonsillitis, otitis media and. Location: FRANCE , child 4 years of age, After Zeclar was administered, patient had the following side effects: condition aggravated, ear pain, headache (What is headache?), infection (What is infection?), oedema, otorrhoea, pyrexia, retinal disorder (What is retinal disorder?), tympanic membrane disorder. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

5244471-X | Alanine Aminotransferase Increased, Blood Albumin Decreased, Blood Alkaline Phosphatase Increased, Blood Immunoglobulin E Increased, Folliculitis, Liver Disorder, Pruritus, Total Bile Acids Increased
on Feb 13, 2007 Female patient from FINLAND , 49 years of age, weighting 138.9 lb, was diagnosed with sinusitis (What is sinusitis?) and was treated with Zeclar (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood immunoglobulin e increased, folliculitis, liver disorder, pruritus, total bile acids increased. Zeclar dosage: .

5234712-7 | Alanine Aminotransferase Increased, Blood Albumin Decreased, Blood Alkaline Phosphatase Increased, Blood Immunoglobulin E Increased, Folliculitis, Pruritus, Total Bile Acids Increased
on Feb 01, 2007 Female patient from FINLAND , 49 years of age, weighting 138.9 lb, was diagnosed with sinusitis (What is sinusitis?) and was treated with Zeclar (View Usage). Patient had the following side effects: alanine aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood immunoglobulin e increased, folliculitis, pruritus, total bile acids increased. Zeclar dosage: .

5215602-2 | Agranulocytosis, Aplasia, Asthenia, Haemoptysis, Pneumonia, Pyrexia
Patient was taking Zeclar (View Usage). After Zeclar was administered, patient had the following side effects: agranulocytosis, aplasia, asthenia, haemoptysis, pneumonia (What is pneumonia?), pyrexia on Jan 12, 2007 from FRANCE Additional patient health information: Female patient , 66 years of age, weighting 121.3 lb, was diagnosed with pyrexia, glaucoma (What is glaucoma?), cough and. Zeclar dosage: . During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ), AMOXICILLINE, ACIDE CLAVULANIQUE (View Amoxicilline, Acide Clavulanique Review and Amoxicilline, Acide Clavulanique Label ), BRINZOLAMIDE (View Brinzolamide Review and Brinzolamide Label ), CLOBUTINOL (View Clobutinol Review and Clobutinol Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), DIURETICS (View Diuretics Review and Diuretics Label ), ACE INHIBITOR NOS (View Ace Inhibitor Nos Review and Ace Inhibitor Nos Label ). Patient was hospitalized.

5213500-1 | Bradycardia, Cardiac Failure, Confusional State, Hyperkalaemia, Oliguria, Overdose, Renal Failure Acute, Renal Impairment, Respiratory Disorder
Adverse event was reported on Jan 10, 2007 by a Female patient taking Zeclar (View Usage) (Dosage: ) was diagnosed with helicobacter infection and. Location: FRANCE , 79 years of age, weighting 112.4 lb, Patient experienced the following unwanted or unexpected effects: bradycardia, cardiac failure, confusional state, hyperkalaemia, oliguria, overdose, renal failure acute, renal impairment, respiratory disorder. During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), GLYCERYL TRINITRATE (View Glyceryl Trinitrate Review and Glyceryl Trinitrate Label ). Patient was hospitalized.

5191529-X | Agranulocytosis, Aphthous Stomatitis, Inflammation, Tongue Ulceration
on Dec 18, 2006 Male patient from FRANCE , 34 years of age, weighting 143.3 lb, was diagnosed with pyrexia, renal transplant, nasopharyngitis and was treated with Zeclar (View Usage). Patient had the following side effects: agranulocytosis, aphthous stomatitis, inflammation, tongue ulceration. Zeclar dosage: . During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CEFIXIME CHEWABLE (View Cefixime Chewable Review and Cefixime Chewable Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), VALACYCLOVIR HCL (View Valacyclovir Hcl Review and Valacyclovir Hcl Label ), SUCARLFATE (View Sucarlfate Review and Sucarlfate Label ). Patient was hospitalized.

5160810-2 | Anorexia, Dehydration, Diarrhoea, Malaise, Pancreatitis Acute, Vertigo
on Aug 03, 2006 Male patient from GERMANY , 70 years of age, was diagnosed with helicobacter infection, giardiasis and was treated with Zeclar (View Usage). After Zeclar was administered, patient had the following side effects: anorexia, dehydration, diarrhoea, malaise, pancreatitis acute, vertigo. Zeclar dosage: . During the same period patient was treated with INIPOMP (View Inipomp Review and Inipomp Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), AMOXICILLIN TRIHYDRATE (View Amoxicillin Trihydrate Review and Amoxicillin Trihydrate Label ). Patient was hospitalized.

5153447-2 | Granulomatous Liver Disease, Hepatic Enzyme Increased, Histiocytosis Haematophagic, Immune Reconstitution Syndrome, Mycobacterial Infection, Oesophageal Candidiasis
Patient was taking Zeclar (View Usage). Patient experienced the following unwanted or unexpected effects: granulomatous liver disease, hepatic enzyme increased, histiocytosis haematophagic, immune reconstitution syndrome, mycobacterial infection, oesophageal candidiasis on Oct 30, 2006 from FRANCE Additional patient health information: Female patient , 32 years of age, was diagnosed with bacterial infection (What is bacterial infection?), hiv infection (What is hiv infection?), respiratory disorder and. Zeclar dosage: . During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), EMTRICITABINE (View Emtricitabine Review and Emtricitabine Label ), SULFAMETHOXAZOLE + TRIMETHOPRIM (View Sulfamethoxazole + Trimethoprim Review and Sulfamethoxazole + Trimethoprim Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), TENOFOVIR DISOPROXIL (View Tenofovir Disoproxil Review and Tenofovir Disoproxil Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), AMOXICILLIN + CLAVULANATE POTASSIUM (View Amoxicillin + Clavulanate Potassium Review and Amoxicillin + Clavulanate Potassium Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ). Patient was hospitalized.

5146340-2 | Granulomatous Liver Disease, Hepatic Enzyme Increased, Histiocytosis Haematophagic, Immune Reconstitution Syndrome, Mycobacterial Infection, Oesophageal Candidiasis
Adverse event was reported on Oct 30, 2006 by a Female patient taking Zeclar (View Usage) (Dosage: ) was diagnosed with bacterial infection (What is bacterial infection?), hiv infection (What is hiv infection?), respiratory disorder and. Location: FRANCE , 32 years of age, Patient had the following side effects: granulomatous liver disease, hepatic enzyme increased, histiocytosis haematophagic, immune reconstitution syndrome, mycobacterial infection, oesophageal candidiasis. During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), EMTRICITABINE (View Emtricitabine Review and Emtricitabine Label ), SULFAMETHOXASONE TRIMETHOPRIME (View Sulfamethoxasone Trimethoprime Review and Sulfamethoxasone Trimethoprime Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), TENOFOVIR DISOPROXIL (View Tenofovir Disoproxil Review and Tenofovir Disoproxil Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), AMOXICILLIN + CLAVULANATE POTASSIUM (View Amoxicillin + Clavulanate Potassium Review and Amoxicillin + Clavulanate Potassium Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ). Patient was hospitalized.

5142866-6 | Blood Creatine Increased, Diarrhoea, Leukocyturia, Nausea, Overdose, Proteinuria, Renal Failure Acute, Renal Impairment, Renal Tubular Disorder
on Oct 11, 2006 Male patient from FRANCE , 37 years of age, weighting 110.2 lb, was diagnosed with atypical mycobacterial infection, cystitis noninfective, antibiotic prophylaxis and was treated with Zeclar (View Usage). After Zeclar was administered, patient had the following side effects: blood creatine increased, diarrhoea, leukocyturia, nausea (What is nausea?), overdose, proteinuria, renal failure acute, renal impairment, renal tubular disorder. Zeclar dosage: . During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), RIFABUTIN (View Rifabutin Review and Rifabutin Label ). Patient was hospitalized.

5131670-0 | Bradycardia, Cardiac Failure, Confusional State, Hyperkalaemia, Oliguria, Overdose, Renal Failure Acute, Renal Impairment, Respiratory Disorder
on Oct 11, 2006 Female patient from FRANCE , 79 years of age, weighting 112.4 lb, was diagnosed with helicobacter infection and was treated with Zeclar (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, cardiac failure, confusional state, hyperkalaemia, oliguria, overdose, renal failure acute, renal impairment, respiratory disorder. Zeclar dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), GLYCERYL TRINITRATE (View Glyceryl Trinitrate Review and Glyceryl Trinitrate Label ). Patient was hospitalized.

5131651-7 | Blood Creatine Increased, Diarrhoea, Leukocyturia, Nausea, Overdose, Proteinuria, Renal Failure Acute, Renal Impairment, Renal Tubular Disorder
Patient was taking Zeclar (View Usage). Patient had the following side effects: blood creatine increased, diarrhoea, leukocyturia, nausea (What is nausea?), overdose, proteinuria, renal failure acute, renal impairment, renal tubular disorder on Oct 11, 2006 from FRANCE Additional patient health information: Male patient , 37 years of age, weighting 110.2 lb, was diagnosed with mycobacterial infection, cystitis noninfective, antibiotic prophylaxis and. Zeclar dosage: . During the same period patient was treated with CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), RIFABUTIN (View Rifabutin Review and Rifabutin Label ), CEFOXITIN (View Cefoxitin Review and Cefoxitin Label ). Patient was hospitalized.

5098427-0 | Anorexia, Dehydration, Diarrhoea, Malaise, Pancreatitis Acute, Vertigo
Adverse event was reported on Aug 03, 2006 by a Male patient taking Zeclar (View Usage) (Dosage: ) was diagnosed with helicobacter infection, giardiasis and. Location: GERMANY , 70 years of age, After Zeclar was administered, patient had the following side effects: anorexia, dehydration, diarrhoea, malaise, pancreatitis acute, vertigo. During the same period patient was treated with INIPOMP (View Inipomp Review and Inipomp Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), AMOXICILLIN TRIHYDRATE (View Amoxicillin Trihydrate Review and Amoxicillin Trihydrate Label ). Patient was hospitalized.

5098405-1 | Anorexia, Dehydration, Diarrhoea, Malaise, Pancreatitis Acute, Vertigo
on Aug 03, 2006 Male patient from GERMANY , 70 years of age, was diagnosed with helicobacter infection, giardiasis and was treated with Zeclar (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, dehydration, diarrhoea, malaise, pancreatitis acute, vertigo. Zeclar dosage: . During the same period patient was treated with INIPOMP (View Inipomp Review and Inipomp Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), AMOXICILLIN TRIHYDRATE (View Amoxicillin Trihydrate Review and Amoxicillin Trihydrate Label ). Patient was hospitalized.

5098403-8 | Anorexia, Dehydration, Diarrhoea, Malaise, Pancreatitis Acute, Vertigo
on Aug 16, 2006 Male patient from GERMANY , 70 years of age, was diagnosed with helicobacter infection, giardiasis and was treated with Zeclar (View Usage). Patient had the following side effects: anorexia, dehydration, diarrhoea, malaise, pancreatitis acute, vertigo. Zeclar dosage: . During the same period patient was treated with INIPOMP (View Inipomp Review and Inipomp Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), AMOXICILLIN TRIHYDRATE (View Amoxicillin Trihydrate Review and Amoxicillin Trihydrate Label ). Patient was hospitalized.

5098340-9 | Anorexia, Dehydration, Diarrhoea, Malaise, Pancreatitis Acute, Vertigo
Patient was taking Zeclar (View Usage). After Zeclar was administered, patient had the following side effects: anorexia, dehydration, diarrhoea, malaise, pancreatitis acute, vertigo on Aug 03, 2006 from GERMANY Additional patient health information: Male patient , 70 years of age, was diagnosed with helicobacter infection, giardiasis and. Zeclar dosage: . During the same period patient was treated with INIPOMP (View Inipomp Review and Inipomp Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), AMOXICILLIN TRIHYDRATE (View Amoxicillin Trihydrate Review and Amoxicillin Trihydrate Label ). Patient was hospitalized.

5095566-5 | Anaemia, Epistaxis, Facial Bones Fracture, Fall, Gingival Bleeding, Head Injury, Hyponatraemia, Vomiting
Adverse event was reported on Aug 23, 2006 by a Female patient taking Zeclar (View Usage) (Dosage: ) . Location: FRANCE , 81 years of age, weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: anaemia, epistaxis, facial bones fracture, fall (What is fall?), gingival bleeding, head injury, hyponatraemia, vomiting. During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ). Patient was hospitalized.

5089353-1 | Anorexia, Dehydration, Diarrhoea, Malaise, Pancreatitis Acute, Vertigo
on Aug 16, 2006 Male patient from GERMANY , 70 years of age, was diagnosed with helicobacter infection, giardiasis and was treated with Zeclar (View Usage). Patient had the following side effects: anorexia, dehydration, diarrhoea, malaise, pancreatitis acute, vertigo. Zeclar dosage: . During the same period patient was treated with INIPOMP (View Inipomp Review and Inipomp Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), AMOXICILLIN TRIHYDRATE (View Amoxicillin Trihydrate Review and Amoxicillin Trihydrate Label ). Patient was hospitalized.

5078396-X | Anorexia, Dehydration, Diarrhoea, Malaise, Pancreatitis Acute, Vertigo
on Aug 03, 2006 Male patient from FRANCE , 70 years of age, was diagnosed with helicobacter infection, giardiasis and was treated with Zeclar (View Usage). After Zeclar was administered, patient had the following side effects: anorexia, dehydration, diarrhoea, malaise, pancreatitis acute, vertigo. Zeclar dosage: . During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), CLAVULANIC ACID/AMOXICILLINE (View Clavulanic Acid/amoxicilline Review and Clavulanic Acid/amoxicilline Label ). Patient was hospitalized.

5051387-0 | Malaise, Rash Maculo-papular, Swelling Face
Patient was taking Zeclar (View Usage). Patient experienced the following unwanted or unexpected effects: malaise, rash maculo-papular, swelling face on Jul 05, 2006 from FRANCE Additional patient health information: Male patient , 74 years of age, was diagnosed with pneumococcal infection and. Zeclar dosage: . Patient was hospitalized.

5022650-4 | Angioneurotic Oedema, Aphonia, Pruritus, Respiratory Distress, Urticaria
Adverse event was reported on Jun 01, 2006 by a Male patient taking Zeclar (View Usage) (Dosage: ) . Location: FRANCE , 40 years of age, weighting 178.6 lb, Patient had the following side effects: angioneurotic oedema, aphonia, pruritus, respiratory distress, urticaria. During the same period patient was treated with TIAPROFENIC ACID (View Tiaprofenic Acid Review and Tiaprofenic Acid Label ), CLOBUTINOL (View Clobutinol Review and Clobutinol Label ), CODEINE+ERYSIMUM+PHOLCODINE (View Codeine+erysimum+pholcodine Review and Codeine+erysimum+pholcodine Label ). Patient was hospitalized.

5022056-8 | Dyspnoea, Toxic Skin Eruption
on May 03, 2006 Female patient from FRANCE , 93 years of age, was diagnosed with helicobacter gastritis and was treated with Zeclar (View Usage). After Zeclar was administered, patient had the following side effects: dyspnoea, toxic skin eruption. Zeclar dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ). Patient was hospitalized.

5010195-7 | Lymphopenia, Neutropenia, Thrombocytopenia
on May 17, 2006 Male patient from FRANCE , 24 years of age, was treated with Zeclar (View Usage). Patient experienced the following unwanted or unexpected effects: lymphopenia, neutropenia, thrombocytopenia. Zeclar dosage: . During the same period patient was treated with ISONIAZID (View Isoniazid Review and Isoniazid Label ), ETHAMBUTOL (View Ethambutol Review and Ethambutol Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), RIFABUTINE (View Rifabutine Review and Rifabutine Label ). Patient was hospitalized.

5010193-3 | Pain In Extremity
Patient was taking Zeclar (View Usage). Patient had the following side effects: pain in extremity on May 17, 2006 from FRANCE Additional patient health information: Female patient , 22 years of age, was diagnosed with ovarian failure, premature menopause and. Zeclar dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), OESTRADIOL (View Oestradiol Review and Oestradiol Label ), PROGESTERONE (View Progesterone Review and Progesterone Label ), VALACYCLOVIR HCL (View Valacyclovir Hcl Review and Valacyclovir Hcl Label ), PHENOZYMETHYLPENICILLINE (View Phenozymethylpenicilline Review and Phenozymethylpenicilline Label ). Patient was hospitalized.